Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome Structure01:17

The Proteasome Structure

1.4K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.4K
The Proteasome02:18

The Proteasome

9.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Circulation research·2026
Same author

Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Fully protected pyrophosphates <i>via</i> phosphorobromidates for the synthesis of biopolymers.

Chemical science·2026
Same author

Catalyzing Carbohydrate Cleavage: Glycosidases and Their Mechanisms.

Chemical reviews·2026
Same author

Modular Synthesis of Nucleoside Diphosphate Sugar Analogues Using Chlorosulfonyl Isocyanate and Dichlorophosphoryl Isocyanate.

Organic letters·2026
Same author

Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.

Journal of medicinal chemistry·2026

Related Experiment Video

Updated: Dec 17, 2025

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.6K

Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.

Elmer Maurits1, Christian G Degeling1, Alexei F Kisselev2

  • 1Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.

Chembiochem : a European Journal of Chemical Biology
|June 30, 2020
PubMed
Summary
This summary is machine-generated.

Researchers developed new fluorogenic substrates to precisely measure the activity of specific proteasome subunits. These tools aid research into proteasome inhibitors for cancer and autoimmune diseases.

Keywords:
Michaelis-Menten kineticsfluorogenic substratesimmunoproteasomekineticsproteasome

More Related Videos

Detection of Protease Activity by Fluorescent Peptide Zymography
09:56

Detection of Protease Activity by Fluorescent Peptide Zymography

Published on: January 20, 2019

13.3K
Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

8.9K

Related Experiment Videos

Last Updated: Dec 17, 2025

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.6K
Detection of Protease Activity by Fluorescent Peptide Zymography
09:56

Detection of Protease Activity by Fluorescent Peptide Zymography

Published on: January 20, 2019

13.3K
Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

8.9K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Proteasomes are critical drug targets for hematological cancers and autoimmune diseases.
  • Existing proteasome inhibitors target specific catalytic subunits (β1c, β1i, β2c, β2i, β5c, β5i).
  • Development of selective assays is crucial for understanding proteasome function and inhibitor efficacy.

Purpose of the Study:

  • To design and synthesize novel fluorogenic substrates.
  • To enable selective measurement of individual proteasome catalytic subunit activities.
  • To expand the research toolbox for proteasome studies.

Main Methods:

  • Modification of mechanism-based proteasome inhibitors by replacing electrophiles with fluorogenic leaving groups.
  • Synthesis of novel fluorogenic substrates based on oligopeptide recognition elements.
  • Assay development to measure proteasome activity in Raji cell lysates and purified 20S proteasomes.

Main Results:

  • Effective fluorogenic substrates were identified for β1c, β1i, β2c, and β5i subunits.
  • Substrates reported on the catalytic activity targeted by parent inhibitors.
  • Low activity was observed for β5c and β2i subunit-selective substrates, indicating limitations.

Conclusions:

  • New subunit-selective fluorogenic substrates were successfully developed for key proteasome components.
  • These substrates enhance the ability to study individual proteasome activities.
  • The findings contribute valuable tools for proteasome-targeted therapeutic research.